Daewoong Pharmaceutical acquires Canadian GMP approval for Nabota factory
The Daewoong Pharmaceutical’s(CEO Seung-Ho Jeon) Nabora factory acquired the cGMP approval from the U.S. FDA on the last 15th, and acquired the GMP approval from the Health Canada on the 18th.
Daewoong Pharmaceutical announced on the 24th that the company received ‘accepted(C: Complaint)’ at the...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.